NBA MVP: коефіцієнти на 2026-27 і 10 головних кандидатів

The voters' second choice (31 ESPN points, 10% of GMs) who sat exactly on the line with 65 games, on a Nuggets team priced at only +2000 to +2800 for the title.

The strongest availability-and-production counterweight to the Wembanyama hype; ESPN gave him 31 points, just three more than Dončić.

A perennial three-time MVP priced at +500 who logged 31 points in ESPN's poll while playing 79 and 77 games across the past two campaigns.

Three-time MVP at +500; voters still respect him (31 pts) but market sees regression risk at age 31

Second on ESPN's panel with 31 points but only 13-16% on Kalshi — and last season he needed the final game just to reach 65.

Three-time MVP whose team is slipping in the West.

Priced at 7% and +1200 even though he played just 36 games last season and must lift a new team into the East's top six.

A new Miami chapter gives the three-time winner a fresh narrative, though the move also means voters must see the Heat as a top team.

Priced at +1000 across sportsbooks, offering top-five statistical output though tempered by Milwaukee's lengthening championship odds.

Bucks' two-time MVP at +900; 15 poll points, 145 games last two seasons

Eight points from ESPN's panel and 8% on Kalshi, but the books drift to +1000-1200 — a two-time MVP on a team the voters' narrative does not automatically follow.

New team in Miami, but +1100 implies just 8.3%.

Third in the GM vote (7%) and priced at 6%, but his 61 games last season fell short of the line and the NBA denied his appeal.

A plausible breakout pick, but his path needs both an MVP-level leap and a Minnesota team strong enough to command voter attention.

Carries +1600 sportsbook odds and 79 games played last season, but needs Minnesota to jump past OKC and San Antonio in the standings.

Timberwolves breakout at +1400; 8 poll points, 157 games last two seasons (league leader)

The only player outside Wembanyama and Jokic to get GM votes (7%) — and the Timberwolves' new LaMelo Ball backcourt is the reason his number can move.

Young star with +1800 odds, but Wolves are +2500.

Priced at +1800 and 6% after playing only 16 games, so the price is a bet on health.

A high-ceiling name whose case depends on recovery and Boston’s changed roster; his preseason forecast signal trails the top four.

Steadily posted 72 and 74 appearances to anchor Boston, hovering at +1800 odds as the Celtics transition their supporting rotation.

Celtics star at +1000; 12 poll points, coming off title but sharing load with Brown

+1100 at FanDuel and +1700-1800 everywhere else — the widest price spread in this top 10, on a team the books like for the title (+1300) more than for the trophy.

Brown gone, offense now entirely his.

The defending champion Knicks offer a strong team platform, but the public forecast evidence puts him behind the leading MVP names.

Fresh off leading the Knicks to the 2026 championship, sitting at +1400 with 11% team title odds backing his narrative.

The reigning Finals MVP (32.6 points per game in the 2026 Finals) is priced +1800 to +5000 — the biggest gap in the race between a trophy already won and a trophy the market won't give him.

Knicks' title hopes, but +3000 for MVP.

Kalshi prices him at 2.5¢ while the AI panel gives him 9.0%, the biggest gap on the board, though he too played only 64 games.

A team-leader route is possible, but Detroit’s title price and the lack of a strong preseason MVP signal keep him outside the main tier.

Priced +1500 at FanDuel and +2200 elsewhere, and the 65-game rule has already touched his case once — he needed an exemption last season too.

Pistons' rise, but 63 games last season.

The 76ers’ ambitious roster raises the team ceiling, but availability is the central question for any MVP case.

Offers +2500 odds but carries the steepest 65-game rule penalty on the board after falling short of award eligibility in two of his last three years.

76ers center at +1600 but only 39 games in 2024-25; 65-game rule is existential risk

76ers added LeBron and Brown, but health is the question.